Global Orally Disintegrating Tablet Market Growth 2023-2029

Global Orally Disintegrating Tablet Market Growth 2023-2029

An orally disintegrating tablet or orally dissolving tablet (ODT) is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medications. ODTs differ from traditional tablets in that they are designed to be dissolved on the tongue rather than swallowed whole. The ODT serves as an alternative dosage form for patients who experience dysphagia (difficulty in swallowing) or for where compliance is a known issue and therefore an easier dosage form to take ensures that medication is taken.
LPI (LP Information)' newest research report, the “Orally Disintegrating Tablet Industry Forecast” looks at past sales and reviews total world Orally Disintegrating Tablet sales in 2022, providing a comprehensive analysis by region and market sector of projected Orally Disintegrating Tablet sales for 2023 through 2029. With Orally Disintegrating Tablet sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Orally Disintegrating Tablet industry.
This Insight Report provides a comprehensive analysis of the global Orally Disintegrating Tablet landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Orally Disintegrating Tablet portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Orally Disintegrating Tablet market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Orally Disintegrating Tablet and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Orally Disintegrating Tablet.
The global Orally Disintegrating Tablet market size is projected to grow from US$ 13590 million in 2022 to US$ 30300 million in 2029; it is expected to grow at a CAGR of 30300 from 2023 to 2029.
Global Orally Disintegrating Tablet main manufactuers include Teva, Merck, Mylan, Pfizer, Johnson and Johnson, GSK, Otsuka, Eli Lilly and Company, AstraZeneca, Bristol-Myers Squibb and Conquer, totally accounting for about 17% of the market. North America is the largest market of glass packaging, holding a share more than 40%. As for the types of products, it can be divided into anti-psychotics drug, anti-epileptics drug and others. As for the applications of products, it is widely used in CNS diseases, gastrointestinal diseases, CVS diseases and others. The most common application is in CNS diseases packaging, with a share about 55%.
This report presents a comprehensive overview, market shares, and growth opportunities of Orally Disintegrating Tablet market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Anti-Psychotics Drug
Anti-Epileptics Drug
Others
Segmentation by application
CNS Diseases
Gastrointestinal Diseases
CVS Diseases
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Teva
Merck
Mylan
Pfizer
Johnson and Johnson
GSK
Otsuka
Eli Lilly and Company
AstraZeneca
Bristol-Myers Squibb
Conquer
Key Questions Addressed in this Report
What is the 10-year outlook for the global Orally Disintegrating Tablet market?
What factors are driving Orally Disintegrating Tablet market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Orally Disintegrating Tablet market opportunities vary by end market size?
How does Orally Disintegrating Tablet break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.